SCHEMBL20602003

SCHEMBL20602003

CC(C)[C@H]1CCC(=O)/C(=C/O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11263966 1.00 — —
SCHEMBL20615600 1.00 — —
SCHEMBL11263963 1.00 — —
SCHEMBL20602038 0.93 — —
SCHEMBL20602039 0.93 — —
SCHEMBL17372084 0.76 NOS3 (0.31) —
SCHEMBL11347138 0.75 CRBN (0.33) —
SCHEMBL11347137 0.75 CRBN (0.33) —
SCHEMBL11258552 0.70 ALDH1A1 (0.35) —
SCHEMBL22699174 0.70 ALDH1A1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019005841-A1 THERAPEUTIC COMPOUNDS AND METHODS TO TREAT INFECTION RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2019-01-03 — — WO disclosed
Send feedback